COMP <GO>
HTFL vs ABBV // ENTERPRISE SCALE & MARKET CAP
Heartflow Inc. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: HTFL 5
— ABBV 9
▲ ENTERPRISE SCALE & MARKET CAP LEADER: ABBV
LAST: $59.05 (-2.45%) • MKT CAP: $5.26B
market-cap
$5.26B
LAST: $294.89 (+1.41%) • MKT CAP: $513.86B
market-cap
$513.86B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HTFL VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HTFL | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 76.80% | 70.20% | +6.60 | HTFL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -12.00% | 29.00% | -41.00 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 33.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.12% | 3.47% | -4.59 | ABBV | /fcf-yield <GO> |
| Operating Margin | -36.40% | 24.60% | -61.00 | ABBV | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 6.90% | -66.90 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 39.90% | 8.60% | +31.30 | HTFL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 5.33 | +20.67 | HTFL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | ABBV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 7.40% | -0.80 | HTFL | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.3 | 72.8 | -5.47 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 1.15 | -0.25 | ABBV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.0x | 113.1x | -86.10 | HTFL | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $5.26B | $513.86B | -$508.60B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HTFL REV | ABBV REV | HTFL GROSS % | ABBV GROSS % | HTFL FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $176.0M | $61.16B | 76.8% | 70.2% | -$59.0M | $17.82B |
| FY 2024 | $125.8M | $56.33B | 75.1% | 70.0% | -$73.4M | $17.83B |
| FY 2023 | $87.2M | $54.32B | 44.0% | 44.0% | -$80.4M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HTFL // BETA 0.90
ABBV // BETA 1.15